Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine—a case report

Acute generalised exanthematous pustulosis (AGEP) is a severe cutaneous adverse reaction characterised by the appearance of erythematous plaques and papules with overlying non-follicular pinpoint pustules. Drugs are the cause of AGEP in approximately 90% of cases. The most common causes include anti-infective agents (aminopenicillins, quinolones, antibacterial sulfonamides and terbinafine), antimalarials and diltiazem. To the best of our knowledge, to date there has only been one report of hydrochlorothiazide-induced AGEP. There has never been a case report of losartan-induced AGEP. Here, we present a case of AGEP that is the second case purportedly caused by hydrochlorothiazide.

Download Full-text

Adverse reaction after tetrathiomolybdate treatment for Wilson's disease: A case report

Movement Disorders ◽

10.1002/mds.21109 ◽

2006 ◽

Vol 21 (11) ◽

pp. 2030-2032 ◽

Cited By ~ 9

Author(s):

Valentina Medici ◽

Carlo Pietro Trevisan ◽

Maria Assunta Bigotto ◽

Renata D'Incà ◽

Diego Martines ◽

...

Keyword(s):

Adverse Reaction ◽

Case Report ◽

Wilson’S Disease ◽

Wilson's Disease

Download Full-text

Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma

Case Reports in Oncology ◽

10.1159/000487128 ◽

2018 ◽

Vol 11 (1) ◽

pp. 119-124 ◽

Cited By ~ 10

Author(s):

Jorine de Haan ◽

Johannes V. van Thienen ◽

Michael Casaer ◽

Rebekka A. Hannivoort ◽

Kristel Van Calsteren ◽

...

Keyword(s):

Adverse Reaction ◽

Case Report ◽

Pregnant Woman ◽

Metastatic Melanoma ◽

Targeted Therapies ◽

Adverse Reactions ◽

Tumour Progression ◽

Single Case ◽

Severe Adverse Reaction ◽

Single Case Report

Targeted therapies have drastically changed the management of metastatic melanoma and have shown encouraging results on tumour progression but are also known for their high rates of adverse reactions. In general, targeted therapies are contraindicated during pregnancy due to concerns about teratogenesis. For the BRAF V600 inhibitor vemurafenib, the available literature about the effects on human pregnancy is limited to a single case report. In patients with metastatic melanoma that wish to continue their pregnancy, targeted therapies like vemurafenib offer the only possibility of improving maternal outcome. In this article, we report on a pregnant woman with metastatic melanoma who was treated with vemurafenib during pregnancy and experienced a fatal adverse reaction.

Download Full-text

Case report: Serious adverse reaction to patent blue violet at lymphography

Clinical Radiology ◽

10.1016/s0009-9260(89)80328-9 ◽

1989 ◽

Vol 40 (6) ◽

pp. 631 ◽

Cited By ~ 15

Author(s):

C.J. Barber

Keyword(s):

Adverse Reaction ◽

Case Report ◽

Patent Blue

Download Full-text

An Osteopathic Approach to Uterine-Induced Low Back Pain: A Case Report

The AAO Journal ◽

10.53702/2375-5717-29.3.23 ◽

2019 ◽

Vol 29 (3) ◽

pp. 23-26

Author(s):

David M. Kanze

Keyword(s):

Adverse Reaction ◽

Low Back Pain ◽

Back Pain ◽

Case Report ◽

Package Insert ◽

The Body ◽

Low Back ◽

Intrauterine Devices ◽

Functional Changes ◽

Uterosacral Ligaments

Abstract Uterine-induced low back pain is primarily caused by pregnancy. More than 50% of women will experience it while pregnant.1 Many of these changes are postural in nature and can last into the postpartum period.1–3 There is also increased stress placed about the uterosacral ligaments and sacrum.1,4–6 Back pain related to intrauterine devices (IUD) is less common than pregnancy-induced back pain, but it is still commonly present and is a common enough adverse reaction that it is listed on the package insert.7 An osteopathic approach to uterine-induced low back pain looks at the structural and functional changes caused by changes in the uterus and the resultant changes on the remainder of the body. The present case depicts this approach and possible anatomic reasoning to why and how this pain is present.

Download Full-text